Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin ImmunoconjugateEric L. Sievers, Irwin D. Bernstein, Kathleen Shannon‐Dorcy et al.|Blood|1999Cited by 456
Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin ImmunoconjugateEric L. Sievers, Irwin D. Bernstein, Frederick R. Appelbaum et al.|Blood|1999Cited by 439
Outcomes after hematopoietic cell transplantation among non-English- compared to English-speaking recipientsAhona Mukherjee, Stephanie J. Lee, Chris Davis et al.|Bone Marrow Transplantation|2022Cited by 8